FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kenneth Bradstock

Research Profile

Disorders

Procedures

Chemicals & Drugs

Antibodies, Monoclonal

Anatomy

Concepts & Ideas

Co-author Network

Publications

TOP 3
Craig T Wallington-Beddoe; Kenneth F Bradstock; Linda Bendall
Oncogenic properties of sphingosine kinases in haematological malignancies.
Robert Welschinger; Jordan Basnett; Kenneth F Bradstock; Aileen Dela Pena; Julius Juarez; Florian Liedtke; Linda Bendall
Plerixafor (AMD3100) induces prolonged mobilization of acute lymphoblastic leukemia cells and increases the proportion of cycling cells in the blood in mice.
I A Bilmon; B George; David Gottlieb; M Hertzberg; G Huang; I Kerridge; J Kwan; M McGurgan; Kenneth F Bradstock
Haploidentical bone marrow transplants for haematological malignancies using non-myeloablative conditioning therapy and post-transplant immunosuppression with cyclophosphamide: results from a single Australian centre.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kenneth Bradstock (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Craig T Wallington-Beddoe; Kenneth F Bradstock; Linda Bendall
Oncogenic properties of sphingosine kinases in haematological malignancies.
British journal of haematology 2013;161(5):623-38.
2013: Robert Welschinger; Jordan Basnett; Kenneth F Bradstock; Aileen Dela Pena; Julius Juarez; Florian Liedtke; Linda Bendall
Plerixafor (AMD3100) induces prolonged mobilization of acute lymphoblastic leukemia cells and increases the proportion of cycling cells in the blood in mice.
Experimental hematology 2013;41(3):293-302.e1.
2013: I A Bilmon; B George; David Gottlieb; M Hertzberg; G Huang; I Kerridge; J Kwan; M McGurgan; Kenneth F Bradstock
Haploidentical bone marrow transplants for haematological malignancies using non-myeloablative conditioning therapy and post-transplant immunosuppression with cyclophosphamide: results from a single Australian centre.
Internal medicine journal 2013;43(2):191-6.
2012: Harry Iland; John Moore; John Reynolds; Michael Seldon; John F Seymour; Shane G Supple; Jeff Szer; John Taper; Kerry Taylor; Campbell Tiley; John Bashford; Kenneth F Bradstock; Peter Browett; Alberto Catalano; Marnie Collins; Juliana Di Iulio; Robin Filshie; Frank Firkin; Andrew Grigg; Mark Hertzberg; Amanda Hugman
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).
Blood 2012;120(8):1570-80; quiz 1752.
2012: B George; N Gilroy; M S Hertzberg; G Huang; I H Kerridge; Kenneth F Bradstock; D J Gottlieb
A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low-, intermediate-, and high-risk groups: reactivation risk is increased by graft-versus-host disease only in the intermediate-risk group.
Transplant infectious disease : an official journal of the Transplantation Society 2012;14(2):141-8.
2012: Naveed I Khan; Rana Baraz; Kenneth F Bradstock; Adam Cisterne; Linda Bendall
Para-NO-aspirin inhibits NF-κB and induces apoptosis in B-cell progenitor acute lymphoblastic leukemia.
Experimental hematology 2012;40(3):207-215.e1.
2012: Harry Iland; John Reynolds; John Seymour; Francisca Springall; Shane Supple; Kerry Taylor; Juliet Ayling; Kenneth F Bradstock; Tim Brighton; Peter Browett; Paul Cannell; Alberto Catalano; John Catalano; Li Chong; Marnie Collins; Sandra Deveridge; Juliana Di Iulio; Andrew Grigg; Mark Hertzberg; Noemi Horvath
Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia.
Haematologica 2012;97(2):227-34.
2012: Julius Juarez; Stuart M Pitson; Michael Rettig; Marilyn Thien; Robert Welschinger; Aileen Dela Pena; Rana Baraz; Kenneth F Bradstock; John F DiPersio; Nadia Harun; Linda Bendall
Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice.
Blood 2012;119(3):707-16.
2012: Craig T Wallington-Beddoe; Kenneth F Bradstock; Anthony S Don; John Hewson; Richard B Lock; Rachael A Papa; Qiao Qiao; Linda Bendall
Disparate in vivo efficacy of FTY720 in xenograft models of Philadelphia positive and negative B-lineage acute lymphoblastic leukemia.
PloS one 2012;7(5):e36429.
2011: Phillip D Fromm; David Gottlieb; Kenneth F Bradstock; Derek N J Hart
Cellular therapy to treat haematological and other malignancies: progress and pitfalls.
Pathology 2011;43(6):605-15.
2011: Ian Nivison-Smith; Judy M Simpson; Jeff Szer; Anthony J Dodds; Richard Doocey; Peter Ganly; John Gibson; David D F Ma; Kenneth F Bradstock
Allogeneic hematopoietic cell transplant for multiple myeloma using reduced intensity conditioning therapy, 1998-2006: factors associated with improved survival outcome.
Leukemia & lymphoma 2011;52(9):1727-35.
2011: Craig T Wallington-Beddoe; Kenneth F Bradstock; John Hewson; Linda Bendall
FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cells.
Autophagy 2011;7(7):707-15.
2011: C Orla Morrissey; Sharon C A Chen; Tania C Sorrell; Kenneth F Bradstock; Jeffrey Szer; Catriona L Halliday; Nicole M Gilroy; Anthony P Schwarer; Monica A Slavin
Design issues in a randomized controlled trial of a pre-emptive versus empiric antifungal strategy for invasive aspergillosis in patients with high-risk hematologic malignancies.
Leukemia & lymphoma 2011;52(2):179-93.
2011: Philip Saunders; Adam Cisterne; Jocelyn Weiss; Kenneth F Bradstock; Linda Bendall
The mammalian target of rapamycin inhibitor RAD001 (everolimus) synergizes with chemotherapeutic agents, ionizing radiation and proteasome inhibitors in pre-B acute lymphocytic leukemia.
Haematologica 2011;96(1):69-77.
2011: Ian Nivison-Smith; Anthony J Dodds; H Dunckley; David D F Ma; J J Moore; J M Simpson; Jeff Szer; Kenneth F Bradstock
Increased activity and improved outcome in unrelated donor haemopoietic cell transplants for acute myeloid leukaemia in Australia, 1992-2005.
Internal medicine journal 2011;41(1a):27-34.
2010: B George; N Pati; N Gilroy; M Ratnamohan; G Huang; I Kerridge; Mark Hertzberg; David Gottlieb; Kenneth F Bradstock
Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
Transplant infectious disease : an official journal of the Transplantation Society 2010;12(4):322-9.
2009: Kenneth F Bradstock; M Hertzberg; I Kerridge; J Svennilson; B George; M McGurgan; G Huang; Vicki Antonenas; David Gottlieb
Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomes.
Internal medicine journal 2009;39(11):744-51.
2009: Ian Nivison-Smith; Judy M Simpson; Anthony J Dodds; David D F Ma; Jeff Szer; Kenneth F Bradstock
Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(10):1323-30.
2009: Shivashni S Gaundar; Kenneth F Bradstock; Linda Bendall
p38MAPK inhibitors attenuate cytokine production by bone marrow stromal cells and reduce stroma-mediated proliferation of acute lymphoblastic leukemia cells.
Cell cycle (Georgetown, Tex.) 2009;8(18):2975-83.
2009: Roman Crazzolara; Kenneth F Bradstock; Linda Bendall
RAD001 (Everolimus) induces autophagy in acute lymphoblastic leukemia.
Autophagy 2009;5(5):727-8.
2009: Julius G Juarez; Marilyn Thien; Aileen Dela Pena; Rana Baraz; Kenneth F Bradstock; Linda Bendall
CXCR4 mediates the homing of B cell progenitor acute lymphoblastic leukaemia cells to the bone marrow via activation of p38MAPK.
British journal of haematology 2009;145(4):491-9.
2009: Andrew Spencer; H Miles Prince; Andrew W Roberts; Ian W Prosser; Kenneth F Bradstock; Luke Coyle; Devinder S Gill; Noemi Horvath; John Reynolds; Nola Kennedy
Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(11):1788-93.
2009: Roman Crazzolara; Adam Cisterne; Marilyn Thien; John Hewson; Rana Baraz; Kenneth F Bradstock; Linda Bendall
Potentiating effects of RAD001 (Everolimus) on vincristine therapy in childhood acute lymphoblastic leukemia.
Blood 2009;113(14):3297-306.
2009: Gary Brooke; Tony Rossetti; Rebecca Pelekanos; Nina Ilic; Patricia Murray; Sonia Hancock; Vicki Antonenas; Gillian Huang; David Gottlieb; Kenneth F Bradstock; Kerry Atkinson
Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials.
British journal of haematology 2009;144(4):571-9.
2008: Kenneth P Micklethwaite; Leighton Clancy; Upinder Sandher; Anna M Hansen; Emily Blyth; Vicki Antonenas; Mary Sartor; Kenneth F Bradstock; David J Gottlieb
Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation.
Blood 2008;112(10):3974-81.
2008: Charles G Mullighan; Susan L Heatley; Silke Danner; Melinda M Dean; Kathleen Doherty; Uwe Hahn; Kenneth F Bradstock; Robyn Minchinton; Anthony P Schwarer; Jeff Szer; Peter G Bardy
Mannose-binding lectin status is associated with risk of major infection following myeloablative sibling allogeneic hematopoietic stem cell transplantation.
Blood 2008;112(5):2120-8.
2008: Naveed I Khan; Adam Cisterne; Meenakshi Devidas; J Shuster; Stephen P Hunger; Peter Shaw; Kenneth F Bradstock; Linda Bendall
Expression of CD44, but not CD44v6, predicts relapse in children with B cell progenitor acute lymphoblastic leukemia lacking adverse or favorable genetics.
Leukemia & lymphoma 2008;49(4):710-8.
2007: Mary Sartor; F Garvin; Vicki Antonenas; Kenneth F Bradstock; David J Gottlieb
Failure to achieve a threshold dose of CD34+ CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation.
Bone marrow transplantation 2007;40(9):851-7.
2007: Emmanuelle Tavernier; Jean-Michel Boiron; Francoise Huguet; Kenneth F Bradstock; Norbert Vey; Tibor J Kovacsovics; André Delannoy; Nathalie Fegueux; Pierre Fenaux; Aspasia Stamatoullas; Olivier Tournilhac; Agnès Buzyn; Oumedaly Reman; Christiane Charrin; Claude Boucheix; Jean Gabert; Véronique Lhéritier; Jean-Paul Vernant; Hervé Dombret; Xavier Thomas
Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial.
Leukemia 2007;21(9):1907-14.
2007: S Feyler; H M Prince; Rachel Pearce; Keiren Towlson; Ian Nivison-Smith; Steve Schey; J Gibson; N Patton; Kenneth F Bradstock; David I Marks; Gordon Cook
The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study.
Bone marrow transplantation 2007;40(5):443-50.
2007: Ian Nivison-Smith; Kenneth F Bradstock; Anthony J Dodds; Patricia A Hawkins; David D F Ma; John J Moore; Judy M Simpson; Jeff Szer
Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(8):905-12.
2007: Naveed I Khan; Kenneth F Bradstock; Linda Bendall
Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia.
British journal of haematology 2007;138(3):338-48.
2007: Kenneth Micklethwaite; Anna Hansen; Aaron Foster; Elizabeth Snape; Vicki Antonenas; Mary Sartor; Peter Shaw; Kenneth F Bradstock; David Gottlieb
Ex vivo expansion and prophylactic infusion of CMV-pp65 peptide-specific cytotoxic T-lymphocytes following allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(6):707-14.
2007: Julius Juarez; A Dela Pena; Rana Baraz; J Hewson; M Khoo; A Cisterne; S Fricker; N Fujii; Kenneth F Bradstock; Linda Bendall
CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment.
Leukemia 2007;21(6):1249-57.
2007: John Moore; Ian Nivison-Smith; Kim Goh; David Ma; Kenneth F Bradstock; Jeff Szer; Simon Durrant; Anthony P Schwarer; Peter Bardy; Richard Herrmann; Anthony J Dodds
Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(5):601-7.
2007: Andrew P Grigg; J Gibson; Peter Bardy; John Reynolds; Peter Shuttleworth; R L Koelmeyer; Jeff Szer; Andrew W Roberts; L Bik To; G Kennedy; Kenneth F Bradstock
A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(5):560-7.
2007: Jenny Lau; Mary Sartor; Kenneth F Bradstock; Slavica Vuckovic; David Munster; Derek N J Hart
Activated circulating dendritic cells after hematopoietic stem cell transplantation predict acute graft-versus-host disease.
Transplantation 2007;83(7):839-46.
2007: Julius Juarez; Rana Baraz; Shivashni Gaundar; Kenneth F Bradstock; Linda Bendall
Interaction of interleukin-7 and interleukin-3 with the CXCL12-induced proliferation of B-cell progenitor acute lymphoblastic leukemia.
Haematologica 2007;92(4):450-9.
2007: Yi-Chiao (Joe) Li; K Micklethwaite; Kenneth F Bradstock; Y-C H Li
Rapid expansion of tumor-reactive cells from HLA-matched siblings for adoptive immunotherapy of melanoma.
Cytotherapy 2007;9(2):133-43.
2006: Larissa Belov; Stephen P Mulligan; Nicole Barber; Adrian Woolfson; Mike Scott; Kerryn Stoner; Jeremy S Chrisp; William A Sewell; Kenneth F Bradstock; Linda Bendall; Dana S Pascovici; Mervyn Thomas; Wendy N Erber; Pauline Huang; Mary Sartor; Graham A R Young; James S Wiley; Surender Juneja; William G Wierda; Anthony R Green; Michael J Keating; Richard I Christopherson
Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray.
British journal of haematology 2006;135(2):184-97.
2006: Andrew P Grigg; Peter Shuttleworth; John Reynolds; Anthony P Schwarer; Jeff Szer; Kenneth F Bradstock; C Hui; R Herrmann; Peter R Ebeling
Pamidronate reduces bone loss after allogeneic stem cell transplantation.
The Journal of clinical endocrinology and metabolism 2006;91(10):3835-43.
2006: David J Gottlieb; Yi-Chiao (Joe) Li; Ilaria Lionello; Silvia Tanzarella; Marina Marangolo; Kenneth F Bradstock; V Russo; Catia Traversari
Generation of tumour-specific cytotoxic T-cell clones from histocompatibility leucocyte antigen-identical siblings of patients with melanoma.
British journal of cancer 2006;95(2):181-8.
2006: Geoffrey R Hill; Edward S Morris; Madonna Fuery; Cheryl Hutchins; Jason Butler; Andrew Grigg; Andrew Roberts; Kenneth F Bradstock; Jeff Szer; Glen Kennedy; James Morton; Simon Durrant
Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(6):603-7.
2006: Kenneth F Bradstock; M S Hertzberg; I H Kerridge; J Svennilson; M McGurgan; G Huang; Vicki Antonenas; David J Gottlieb
Unrelated umbilical cord blood transplantation for adults with haematological malignancies: results from a single Australian centre.
Internal medicine journal 2006;36(6):355-61.
2006: M S Hertzberg; C Crombie; W Benson; J Taper; David Gottlieb; Kenneth F Bradstock
Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17 Suppl 4():iv25-30.
2006: M Hertzberg; Andrew Grigg; David Gottlieb; J Szer; A Roberts; R Hoyt; G Huang; Kenneth F Bradstock
Reduced-intensity allogeneic haemopoietic stem cell transplantation induces durable responses in patients with chronic B-lymphoproliferative disorders.
Bone marrow transplantation 2006;37(10):923-8.
2006: Catriona Halliday; Rebecca Hoile; Tania C Sorrell; Gregory James; Satya Yadav; Peter Shaw; Marie Bleakley; Kenneth F Bradstock; Sharon Chen
Role of prospective screening of blood for invasive aspergillosis by polymerase chain reaction in febrile neutropenic recipients of haematopoietic stem cell transplants and patients with acute leukaemia.
British journal of haematology 2006;132(4):478-86.
2006: Nathalie Dhédin; Hervé Dombret; Xavier Thomas; Véronique Lhéritier; Jean-Michel Boiron; Françoise Rigal-Huguet; Norbert Vey; Mathieu Kuentz; Oumedaly Reman; Francis Witz; André Delannoy; Tibor J Kovacsovics; Kenneth F Bradstock; Christiane Charrin; Claude Boucheix; Jean Gabert; Didier Blaise; Denis Fière; Jean-Paul Vernant
Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trials.
Leukemia 2006;20(2):336-44.
2006: H Crowther; D Collins; Vicki Antonenas; M McGurgan; I Kerridge; David Gottlieb; Kenneth F Bradstock
Successful autologous peripheral blood stem cell harvest and transplant in a patient with cold agglutinins.
Bone marrow transplantation 2006;37(3):329-30.
2006: Vicki Antonenas; F Garvin; M Webb; Mary Sartor; Kenneth F Bradstock; David Gottlieb
Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport.
Cytotherapy 2006;8(2):158-65.
2005: Mary Sartor; Vicki Antonenas; F Garvin; M Webb; Kenneth F Bradstock
Recovery of viable CD34+ cells from cryopreserved hemopoietic progenitor cell products.
Bone marrow transplantation 2005;36(3):199-204.
2005: Dario Campana; Shotaro Iwamoto; Linda Bendall; Kenneth F Bradstock
Growth requirements and immunophenotype of acute lymphoblastic leukemia progenitors.
Blood 2005;105(10):4150.
2005: Norbert Schmitz; Meral Beksac; Andrea Bacigalupo; Tapani Ruutu; Arnon Nagler; Eliane Gluckman; Nigel Russell; Jane Apperley; Jeff Szerm; Kenneth F Bradstock; Agnès Buzyn; Brigitte Schlegelberger; James Matcham; Alois Gratwohl
Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial.
Haematologica 2005;90(5):643-8.
2005: Linda Bendall; Rana Baraz; Julius Juarez; Wei Shen; Kenneth F Bradstock
Defective p38 mitogen-activated protein kinase signaling impairs chemotaxic but not proliferative responses to stromal-derived factor-1alpha in acute lymphoblastic leukemia.
Cancer research 2005;65(8):3290-8.
2005: Andrew P Grigg; John Reynolds; A McQuillan; Surender Juneja; J Di Iulio; C Hui; C Smith; R Kimber; Kenneth F Bradstock
Prognostic features for response and survival in elderly patients with de novo acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine.
Leukemia & lymphoma 2005;46(3):367-75.
2005: Kenneth F Bradstock; Jane P Matthews; Raymond Lowenthal; Heather Baxter; John Catalano; Timothy Brighton; Devinder Gill; Paul Eliadis; Douglas Joshua; Paul Cannell; Anthony P Schwarer; Simon Durrant; Anne Gillett; Jerry Koutts; Kerry Taylor; John Bashford; Chris Arthur; Arno Enno; Lindsay Dunlop; Jeff Szer; Michael F Leahy; Surender Juneja; Graham A R Young
A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine.
Blood 2005;105(2):481-8.
2005: Ian Nivison-Smith; Kenneth F Bradstock; A J Dodds; P A Hawkins; Jeff Szer
Haemopoietic stem cell transplantation in Australia and New Zealand, 1992-2001: progress report from the Australasian Bone Marrow Transplant Recipient Registry.
Internal medicine journal 2005;35(1):18-27.
2004: A A Erdstein; P Daas; Kenneth F Bradstock; T Robinson; M S Hertzberg
Tuberculosis in allogeneic stem cell transplant recipients: still a problem in the 21st century.
Transplant infectious disease : an official journal of the Transplantation Society 2004;6(4):142-6.
2004: PN Mollee; C Arthur; T Hughes; H Januszewicz; Andrew Grigg; Kenneth F Bradstock; Max Wolf; J Gibson; Anthony P Schwarer; A Spencer; Peter Browett; T Hawkins; M Seldon; R Herrmann; A Watson; John F Seymour; N Martin; S Shina; C Low; S Wright; Robyn Rodwell; J Coulston; J Morton; H Blacklock; D Taylor; K M Taylor
Interferon-alpha-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemia.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(12):1810-5.
2004: Aaron E Foster; Kenneth F Bradstock; Uluhan Sili; Marina Marangolo; Cliona M Rooney; David J Gottlieb
A comparison of gene transfer and antigen-loaded dendritic cells for the generation of CD4+ and CD8+ cytomegalovirus-specific T cells in HLA-A2+ and HLA-A2- donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(11):761-71.
2004: Susan Branford; Zbigniew Rudzki; Ian Parkinson; Andrew Grigg; Kerry Taylor; John F Seymour; Simon Durrant; Peter Browett; Anthony P Schwarer; Chris Arthur; John Catalano; Michael F Leahy; Robin Filshie; Kenneth F Bradstock; Richard Herrmann; David Joske; Kevin Lynch; Timothy Hughes
Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations.
Blood 2004;104(9):2926-32.
2004: Xavier Thomas; Jean-Michel Boiron; Francoise Huguet; Hervé Dombret; Kenneth F Bradstock; Norbert Vey; Tibor J Kovacsovics; André Delannoy; Nathalie Fegueux; Pierre Fenaux; Aspasia Stamatoullas; Jean-Paul Vernant; Olivier Tournilhac; Agnès Buzyn; Oumedaly Reman; Christiane Charrin; Claude Boucheix; Jean Gabert; Véronique Lhéritier; Denis Fiere
Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(20):4075-86.
2004: Aaron E Foster; Marina Marangolo; Mary Sartor; Stephen I Alexander; Min Hu; Kenneth F Bradstock; David J Gottlieb
Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion.
Blood 2004;104(8):2403-9.
2004: Vicki Antonenas; Peter Shaw; Kenneth F Bradstock
Infusion of unwashed umbilical cord blood stem cells after thawing for allogeneic transplantation.
Bone marrow transplantation 2004;34(8):739.
2004: Linda Bendall; Susan K Nilsson; Naveed I Khan; A James; C Bonnet; R B Lock; Rachael A Papa; Kenneth F Bradstock; David J Gottlieb
Role of CD44 variant exon 6 in acute lymphoblastic leukaemia: association with altered bone marrow localisation and increased tumour burden.
Leukemia 2004;18(7):1308-11.
2004: Jeff Szer; Simon Durrant; Anthony P Schwarer; Kenneth F Bradstock; J Gibson; Chris Arthur; L Bik To; T Hughes; H Raunow
Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation.
Internal medicine journal 2004;34(3):98-101.
2004: Eileen Mary McGowan; Sonia Saad; Linda Bendall; Kenneth F Bradstock; Christine L Clarke
Effect of progesterone receptor a predominance on breast cancer cell migration into bone marrow fibroblasts.
Breast cancer research and treatment 2004;83(3):211-20.
2004: Aaron E Foster; Kurt Forrester; David J Gottlieb; Geoffrey W Barton; Jose A Romagnoli; Kenneth F Bradstock
Large-scale expansion of cytomegalovirus-specific cytotoxic T cells in suspension culture.
Biotechnology and bioengineering 2004;85(2):138-46.
2004: Julius Juarez; Linda Bendall; Kenneth F Bradstock
Chemokines and their receptors as therapeutic targets: the role of the SDF-1/CXCR4 axis.
Current pharmaceutical design 2004;10(11):1245-59.
2003: Susan Branford; Zbigniew Rudzki; A Harper; Andrew Grigg; Kerry Taylor; Simon Durrant; Chris Arthur; Peter Browett; Anthony P Schwarer; D Ma; John F Seymour; Kenneth F Bradstock; David Joske; Kevin Lynch; Insa Gathmann; Timothy P Hughes
Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase.
Leukemia 2003;17(12):2401-9.
2003: G Favre; M Beksaç; Andrea Bacigalupo; Tapani Ruutu; Arnon Nagler; Eliane Gluckman; Nigel Russell; J Apperley; Jeff Szer; Kenneth F Bradstock; Agnès Buzyn; James Matcham; Alois Gratwohl; Norbert Schmitz
Differences between graft product and donor side effects following bone marrow or stem cell donation.
Bone marrow transplantation 2003;32(9):873-80.
2003: Linda Bendall; Alexander James; Andrew C W Zannettino; Paul J Simmons; David J Gottlieb; Kenneth F Bradstock
A novel CD44 antibody identifies an epitope that is aberrantly expressed on acute lymphoblastic leukaemia cells.
Immunology and cell biology 2003;81(4):311-9.
2003: Julius Juarez; Kenneth F Bradstock; David J Gottlieb; Linda Bendall
Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro.
Leukemia 2003;17(7):1294-300.
2003: David Lee; Shivakumar Chitturi; James G Kench; Jacob George; Steven Fuller; Kenneth F Bradstock; Rita Lin; Kai Ping Wong; Noel Young
Transjugular liver biopsy effecting changes in clinical management.
Australasian radiology 2003;47(2):117-20.
2003: Slavica Vuckovic; Min Kim; Dalia Khalil; Cameron J Turtle; Georgina Crosbie; Noel Williams; Len Brown; Katrina Williams; Cathryn Kelly; Penny Stravos; Robyn Rodwell; Geoffrey R Hill; Susan Wright; Kerry Taylor; Devinder Gill; Paula Marlton; Kenneth F Bradstock; Derek N J Hart
Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression.
Blood 2003;101(6):2314-7.
2003: Andrew C W Zannettino; Maria Roubelakis; Katie Welldon; Denise E Jackson; Paul J Simmons; Linda Bendall; Anthony Henniker; Kate L Harrison; Silvana Niutta; Kenneth F Bradstock; Suzanne M Watt
Novel mesenchymal and haematopoietic cell isoforms of the SHP-2 docking receptor, PZR: identification, molecular cloning and effects on cell migration.
The Biochemical journal 2003;370(Pt 2):537-49.
2003: Aaron E Foster; David J Gottlieb; Marina Marangolo; Anna Bartlett; Yi-Chiao (Joe) Li; Geoffrey W Barton; Jose A Romagnoli; Kenneth F Bradstock
Rapid, large-scale generation of highly pure cytomegalovirus-specific cytotoxic T cells for adoptive immunotherapy.
Journal of hematotherapy & stem cell research 2003;12(1):93-105.
2003: M S Hertzberg; C Crombie; W Benson; J Taper; David Gottlieb; Kenneth F Bradstock
Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin's lymphoma and Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14 Suppl 1():i11-6.
2002: André Bosly; Michael J Keating; Roberto Stasi; Kenneth F Bradstock
Rituximab in B-cell disorders other than non-Hodgkin's lymphoma.
Anti-cancer drugs 2002;13 Suppl 2():S25-33.
2002: Norbert Schmitz; Meral Beksac; Dirk Hasenclever; Andrea Bacigalupo; Tapani Ruutu; Arnon Nagler; Eliane Gluckman; Nigel Russell; Jane F Apperley; Norbert-Claude Gorin; Jeff Szer; Kenneth F Bradstock; Agnès Buzyn; Peter Clark; Keith Borkett; Alois Gratwohl
Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia.
Blood 2002;100(3):761-7.
2002: Aaron E Foster; David J Gottlieb; Mary Sartor; Mark S Hertzberg; Kenneth F Bradstock
Cytomegalovirus-specific CD4+ and CD8+ T-cells follow a similar reconstitution pattern after allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(9):501-11.
2002: Kenneth F Bradstock
The use of hematopoietic growth factors in the treatment of acute leukemia.
Current pharmaceutical design 2002;8(5):343-55.
2002: Sonia Saad; David J Gottlieb; Kenneth F Bradstock; Christopher M Overall; Linda Bendall
Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts.
Cancer research 2002;62(1):283-9.
2001: W Shen; Linda Bendall; David J Gottlieb; Kenneth F Bradstock
The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow.
Experimental hematology 2001;29(12):1439-47.
2001: Kenneth F Bradstock; J Matthews; G Young; Raymond Lowenthal; Heather Baxter; Chris Arthur; John Bashford; T Brighton; Paul Cannell; Lindsay Dunlop; Simon Durrant; Arno Enno; Paul Eliadis; Devinder Gill; A Gillett; David Gottlieb; H Januszewicz; Douglas Joshua; Michael F Leahy; Anthony P Schwarer; Kerry Taylor
Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia.
Leukemia 2001;15(9):1331-8.
2001: Ian Nivison-Smith; Kenneth F Bradstock; Jeff Szer; Simon Durrant; Anthony J Dodds; R Hermann; Anthony P Schwarer; J Gibson; L Bik To; C Arthur
Allogeneic haemopoietic cell transplants in Australia, 1996--a multi-centre retrospective comparison of the use of peripheral blood stem cells with bone marrow.
Bone marrow transplantation 2001;28(1):21-7.
2001: Jane P Matthews; JF Bishop; Graham A R Young; Surender Juneja; Raymond Lowenthal; O M Garson; Ralph Cobcroft; A J Dodds; Arno Enno; E A Gillett; R P Hermann; Douglas Joshua; David D F Ma; Jeff Szer; K M Taylor; M Wolf; Kenneth F Bradstock
Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia.
British journal of haematology 2001;113(3):727-36.
2000: Sonia Saad; Linda Bendall; A James; David J Gottlieb; Kenneth F Bradstock
Induction of matrix metalloproteinases MMP-1 and MMP-2 by co-culture of breast cancer cells and bone marrow fibroblasts.
Breast cancer research and treatment 2000;63(2):105-15.
2000: Linda Bendall; Kenneth F Bradstock; David J Gottlieb
Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells.
Leukemia 2000;14(7):1239-46.
2000: Kenneth F Bradstock; V Makrynikola; A Bianchi; W Shen; J Hewson; David J Gottlieb
Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers.
Leukemia 2000;14(5):882-8.
2000: Kazunori Nakase; Kenneth F Bradstock; Mary Sartor; David Gottlieb; K Byth; Kenkichi Kita; Hiroshi Shiku; Nanao Kamada
Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: a comparative study of Australian and Japanese adult cases.
Leukemia 2000;14(1):163-8.
1999: Andrew P Grigg; Jeff Szer; J Beresford; A Dodds; Kenneth F Bradstock; Simon Durrant; Anthony P Schwarer; T Hughes; Richard Herrmann; J Gibson; Chris Arthur; J Matthews
Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemia.
British journal of haematology 1999;107(2):409-18.
1999: Raymond Lowenthal; Kenneth F Bradstock; Jane P Matthews; JF Bishop; Surender Juneja; Ralph Cobcroft; Paul Eliadis; Arno Enno; Devinder Gill; R P Herrmann; A Manoharan; F J Page; K F Rooney; D Rosenfeld; Michael Seldon; K M Taylor; Max M Wolf; Graham A R Young
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG).
Leukemia & lymphoma 1999;34(5-6):501-10.
1999: A A Bhave; K Thirunavukkarasu; David J Gottlieb; Kenneth F Bradstock
Disseminated nocardiosis in a bone marrow transplant recipient with chronic GVHD.
Bone marrow transplantation 1999;23(5):519-21.
1998: U Brandenburg; David Gottlieb; Kenneth F Bradstock
Antileukemic effects of rapid cyclosporin withdrawal in patients with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation.
Leukemia & lymphoma 1998;31(5-6):545-50.
1998: Robin Filshie; David Gottlieb; Kenneth F Bradstock
VLA-4 is involved in the engraftment of the human pre-B acute lymphoblastic leukaemia cell line NALM-6 in SCID mice.
British journal of haematology 1998;102(5):1292-300.
1998: Linda Bendall; V Makrynikola; A Hutchinson; A C Bianchi; Kenneth F Bradstock; David J Gottlieb
Stem cell factor enhances the adhesion of AML cells to fibronectin and augments fibronectin-mediated anti-apoptotic and proliferative signals.
Leukemia 1998;12(9):1375-82.
1998: Robin Filshie; Andrew C W Zannettino; V Makrynikola; Stan Gronthos; A J Henniker; Linda Bendall; David J Gottlieb; Paul J Simmons; Kenneth F Bradstock
MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignancies.
Leukemia 1998;12(3):414-21.
1998: JF Bishop; Jane P Matthews; Graham A R Young; Kenneth F Bradstock; Raymond Lowenthal
Intensified induction chemotherapy with high dose cytarabine and etoposide for acute myeloid leukemia: a review and updated results of the Australian Leukemia Study Group.
Leukemia & lymphoma 1998;28(3-4):315-27.
1997: Linda Bendall; Jason P Kirkness; A Hutchinson; A Bianchi; V Makrynikola; Kenneth F Bradstock; David J Gottlieb
Antibodies to CD44 enhance adhesion of normal CD34+ cells and acute myeloblastic but not lymphoblastic leukaemia cells to bone marrow stroma.
British journal of haematology 1997;98(4):828-37.
1997: Douglas Joshua; R Penny; Jane P Matthews; CR Laidlaw; John Gibson; Kenneth F Bradstock; M Wolf; D Goldstein
Australian Leukaemia Study Group myeloma II: a randomized trial of intensive combination chemotherapy with or without interferon in patients with myeloma.
British journal of haematology 1997;97(1):38-45.
1996: Linda Bendall; Kenneth F Bradstock; David J Gottlieb
Identification of novel K562 membrane proteins that adhere to bone marrow fibroblasts.
Blood 1996;88(1):277-88.
1996: J Brisco; E Hughes; SH Neoh; Pamela J Sykes; Kenneth F Bradstock; Arno Enno; Jeff Szer; Kieran McCaul; Alexander A Morley
Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia.
Blood 1996;87(12):5251-6.
1996: Kenneth F Bradstock; A Bianchi; V Makrynikola; R Filshie; David Gottlieb
Long-term survival and proliferation of precursor-B acute lymphoblastic leukemia cells on human bone marrow stroma.
Leukemia 1996;10(5):813-20.
1996: JF Bishop; Jane P Matthews; G A Young; Jeff Szer; A Gillett; Douglas Joshua; Kenneth F Bradstock; Arno Enno; M M Wolf; R Fox; R Cobcroft; R Herrmann; M Van Der Weyden; Raymond Lowenthal; F Page; O M Garson; Surender Juneja
A randomized study of high-dose cytarabine in induction in acute myeloid leukemia.
Blood 1996;87(5):1710-7.
1996: J Hewson; A Bianchi; Kenneth F Bradstock; V Makrynikola; David Gottlieb
Ultrastructural changes during adhesion and migration of pre-B lymphoid leukaemia cells within bone marrow stroma.
British journal of haematology 1996;92(1):77-87.
1995: V Makrynikola; Emmanuel Favaloro; T Browning; A Bianchi; Kenneth F Bradstock
Functional and phenotypic upregulation of CD13/aminopeptidase-N on precursor-B acute lymphoblastic leukemia after in vitro stimulation.
Experimental hematology 1995;23(11):1173-9.
1995: K Atkinson; Chris Arthur; Kenneth F Bradstock; B Dale; K Downs; J Gibson; M Golenia; J Ho; D Joshua; C Juttner
Prophylactic ganciclovir is more effective in HLA-identical family member marrow transplant recipients than in more heavily immune-suppressed HLA-identical unrelated donor marrow transplant recipients. Australasian Bone Marrow Transplant Study Group.
Bone marrow transplantation 1995;16(3):401-5.
1995: Emmanuel Favaloro; T Browning; H Nandurkar; M Sartor; Kenneth F Bradstock; Jerry Koutts
Aminopeptidase-N (CD13; gp 150): contrasting patterns of enzymatic activity in blood from patients with myeloid or lymphoid leukemia.
Leukemia research 1995;19(9):659-66.
1995: Kenneth F Bradstock; David J Gottlieb
Interaction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual disease.
Leukemia & lymphoma 1995;18(1-2):1-16.
1995: Linda Bendall; K Kortlepel; Kenneth F Bradstock; David J Gottlieb
Natural killer cells adhere to bone marrow fibroblasts and inhibit adhesion of acute myeloid leukemia cells.
Leukemia 1995;9(6):999-1005.
1995: A Srivastava; D Gottlieb; Kenneth F Bradstock
Diffuse alveolar haemorrhage associated with microangiopathy after allogeneic bone marrow transplantation.
Bone marrow transplantation 1995;15(6):863-7.
1995: M Tschuchnigg; William A Sewell; B G Kennedy; Kenneth F Bradstock
Molecular analysis of CD2 gene expression in acute myeloblastic leukemia expressing T-lineage associated surface antigens.
Leukemia & lymphoma 1995;16(3-4):281-8.
1994: Peter Shaw; M E Bergin; M A Burgess; L Dalla Pozza; S J Kellie; G Rowell; M M Stevens; B H Webster; Kenneth F Bradstock
Childhood acute myeloid leukemia: outcome in a single center using chemotherapy and consolidation with busulfan/cyclophosphamide for bone marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(10):2138-45.
1994: V Makrynikola; A Bianchi; Kenneth F Bradstock; David Gottlieb; J Hewson
Migration of acute lymphoblastic leukemia cells into human bone marrow stroma.
Leukemia 1994;8(10):1734-43.
1994: Kenneth F Bradstock; J Matthews; E Benson; F Page; J Bishop
Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group.
Blood 1994;84(4):1220-5.
1994: S Greenaway; A J Henniker; M Walsh; Kenneth F Bradstock
A pilot clinical trial of two murine monoclonal antibodies fixing human complement in patients with chronic lymphatic leukaemia.
Leukemia & lymphoma 1994;13(3-4):323-31.
1994: R L Ward; A J Henniker; G Smith; Kenneth F Bradstock; K Atkinson; J C Biggs
Characterization of a novel leucocyte surface membrane antigen recognized by the monoclonal antibody WM65.
Immunology and cell biology 1994;72(1):49-55.
1993: Kenneth F Bradstock; V Makrynikola; A Bianchi; K Byth
Analysis of the mechanism of adhesion of precursor-B acute lymphoblastic leukemia cells to bone marrow fibroblasts.
Blood 1993;82(11):3437-44.
1993: Kenneth F Bradstock; C Luxford; P G Grimsley
Functional and phenotypic assessment of neonatal human leucocytes expressing natural killer cell-associated antigens.
Immunology and cell biology 1993;71 ( Pt 6)():535-42.
1993: Kenneth F Bradstock
The diagnostic and prognostic value of immunophenotyping in acute leukemia.
Pathology 1993;25(4):367-74.
1993: A J Henniker; Kenneth F Bradstock
Purification of two murine monoclonal antibodies of the IgM class by hydroxylapatite chromatography and gel filtration.
Biomedical chromatography : BMC 1993;7(3):121-5.
1993: V Makrynikola; Kenneth F Bradstock
Adhesion of precursor-B acute lymphoblastic leukaemia cells to bone marrow stromal proteins.
Leukemia 1993;7(1):86-92.
1992: B Kramer; V Makrynikola; Kenneth F Bradstock
Effects of mafosfamide on the clonogenic cells in precursor B acute lymphoblastic leukemia: significance for ex vivo purging of bone marrow.
Progress in clinical and biological research 1992;377():41-7.
1991: V Makrynikola; A Kabral; Kenneth F Bradstock
Effect of mafosfamide (ASTA-Z-7654) on the clonogenic cells in precursor-B acute lymphoblastic leukaemia: significance for ex vivo purging of bone marrow for autologous transplantation.
Bone marrow transplantation 1991;8(5):351-5.
1991: K Atkinson; Jim Biggs; K Downs; C Juttner; Kenneth F Bradstock; Raymond Lowenthal; B Dale; J Szer
GM-CSF after allogeneic bone marrow transplantation: accelerated recovery of neutrophils, monocytes and lymphocytes.
Australian and New Zealand journal of medicine 1991;21(5):686-92.
1991: V Makrynikola; A Kabral; Kenneth F Bradstock
Effects of recombinant human cytokines on precursor-B acute lymphoblastic leukemia cells.
Experimental hematology 1991;19(7):674-9.
1991: V Makrynikola; A Kabral; Kenneth F Bradstock
Effects of interleukin 7 on the growth of clonogenic cells in T-cell acute lymphoblastic leukaemia.
Leukemia research 1991;15(10):879-82.
1990: M Alkam; Kenneth F Bradstock; W G Hughes; N Watson; I Bowyer
Spontaneous complete remission of chronic myeloid leukaemia following haematological relapse after allogeneic bone marrow transplantation.
Australian and New Zealand journal of medicine 1990;20(5):710-2.
1990: A J Henniker; Kenneth F Bradstock; P Grimsley; M K Atkinson
A novel non-lineage antigen on human leucocytes: characterization with two CD-48 monoclonal antibodies.
Disease markers 1990;8(4):179-90.
1990: Emmanuel Favaloro; N Moraitis; Kenneth F Bradstock; Jerry Koutts
Co-expression of haemopoietic antigens on vascular endothelial cells: a detailed phenotypic analysis.
British journal of haematology 1990;74(4):385-94.
1990: Kenneth F Bradstock; J Posen; A Kabral; W G Hughes; Jerry Koutts; T I Robertson; C H Lee; P A Castaldi
Autologous bone marrow transplantation for acute myeloid leukaemia in remission: a preliminary report.
Australian and New Zealand journal of medicine 1990;20(1):26-31.
1990: M Tschuchnigg; Kenneth F Bradstock; Jerry Koutts; J Stewart; Arno Enno; Michael Seldon
A case of thrombotic thrombocytopenic purpura following allogeneic bone marrow transplantation.
Bone marrow transplantation 1990;5(1):61-3.
1990: CA Juttner; L Bik To; David N Haylock; P G Dyson; Kenneth F Bradstock; B M Dale; Arno Enno; R E Sage; Jeff Szer; IR Toogood
Approaches to blood stem cell mobilisation. Initial Australian clinical results.
Bone marrow transplantation 1990;5 Suppl 1():22-4.
1990: G Davey; Kenneth F Bradstock; R F Kefford; Y Wishart; A Kabral; P Grimsley; W G Hughes
Lack of correlation between immunoglobulin and T cell receptor gene rearrangements and TdT expression in acute myeloid leukaemia.
Leukemia research 1990;14(1):77-83.
1989: A M Hudson; V Makrynikola; A Kabral; Kenneth F Bradstock
Immunophenotypic analysis of clonogenic cells in acute lymphoblastic leukemia using an in vitro colony assay.
Blood 1989;74(6):2112-20.
1989: Kenneth F Bradstock; J Kirk; P G Grimsley; A Kabral; W G Hughes
Unusual immunophenotypes in acute leukaemias: incidence and clinical correlations.
British journal of haematology 1989;72(4):512-8.
1989: S R Tamat; A Patwardhan; Douglas E Moore; A Kabral; Kenneth F Bradstock; P Hersey; Barry J Allen
Boronated monoclonal antibodies for potential neutron capture therapy of malignant melanoma and leukaemia.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1989;165(2-3):145-7.
1989: A Henniker; Kenneth F Bradstock; K Atkinson; S Barclay; A Kabral; P Grimsley
Expression of a novel human pan leucocyte differentiation antigen on leukaemic cells.
Leukemia research 1989;13(8):689-97.
1988: Kenneth F Bradstock; A Kerr; P Grimsley; J Kirk; C Luxford
Phenotypic characterization of immature lymphoid cells in human umbilical cord blood.
Immunology and cell biology 1988;66 ( Pt 5-6)():387-94.
1988: Kenneth F Bradstock; Jerry Koutts; A Stanton; C H Lee; T I Robertson; P Castaldi; S Kamath; J Carter; M Greenberg
Improved treatment results for lymphoblastic lymphoma in adolescents and adults using a doxorubicin-based (APO) protocol.
Australian and New Zealand journal of medicine 1988;18(4):563-8.
1988: Emmanuel Favaloro; Kenneth F Bradstock; A Kabral; P Grimsley; H Zowtyj; H Zola
Further characterization of human myeloid antigens (gp160,95; gp150; gp67): investigation of epitopic heterogeneity and non-haemopoietic distribution using panels of monoclonal antibodies belonging to CD-11b, CD-13 and CD-33.
British journal of haematology 1988;69(2):163-71.
1988: M C Berndt; A Kabral; P Grimsley; N Watson; T I Robertson; Kenneth F Bradstock
An acquired Bernard-Soulier-like platelet defect associated with juvenile myelodysplastic syndrome.
British journal of haematology 1988;68(1):97-101.
1988: A Kabral; Kenneth F Bradstock; P Grimsley; Emmanuel Favaloro
Immunophenotype of clonogenic cells in myeloid leukaemia.
Leukemia research 1988;12(1):51-9.
1987: Emmanuel Favaloro; Kenneth F Bradstock; A Kabral; P Grimsley; M C Berndt
Characterization of monoclonal antibodies to the human myeloid-differentiation antigen, 'gp67' (CD-33).
Disease markers 1987;5(4):215-25.
1987: Emmanuel Favaloro; Kenneth F Bradstock; A Grimsley; A Henniker; S Kamath
Further studies on the heterogeneity of antigens recognised by CD-1 monoclonal antibodies: distribution of epitopes and analysis of serological binding patterns.
Immunology and cell biology 1987;65 ( Pt 6)():517-27.
1987: David Gottlieb; Kenneth F Bradstock; Jerry Koutts; T Robertson; C Lee; P Castaldi
The neurotoxicity of high-dose cytosine arabinoside is age-related.
Cancer 1987;60(7):1439-41.
1987: Kenneth F Bradstock; M Stevens; M Bergin; L Dalla-Pozza; P Duval; Emmanuel Favaloro; A Kabral; A Kerr; CA Juttner; Heddy Zola
Transplantation of monoclonal antibody-purged autologous bone marrow for treatment of poor risk common acute lymphoblastic leukemia.
Australian and New Zealand journal of medicine 1987;17(3):283-9.
1987: Kenneth F Bradstock; M M Prendergast; W G Hughes; A F Broomhead; A Kabral; K Tiver
Resistance to engraftment in irradiated dogs receiving T cell-depleted bone marrow transplants.
Transplantation proceedings 1987;19(2):2902-6.
1987: Heddy Zola; A Potter; SH Neoh; CA Juttner; David N Haylock; A M Rice; Emmanuel Favaloro; A Kabral; Kenneth F Bradstock
Evaluation of a monoclonal IgM antibody for purging of bone marrow for autologous transplantation.
Bone marrow transplantation 1987;1(3):297-301.
1986: Emmanuel Favaloro; Kenneth F Bradstock; S Kamath; G Dowden; D Gillis; V George
Characterization of a p43 human thymocyte antigen.
Disease markers 1986;4(4):261-70.
1986: Kenneth F Bradstock; A Kerr; A Kabral; Emmanuel Favaloro; J W Hewson
Coexpression of p165 myeloid surface antigen and terminal deoxynucleotidyl transferase: a comparison of acute myeloid leukaemia and normal bone marrow cells.
American journal of hematology 1986;23(1):43-50.
1986: M M Prendergast; Kenneth F Bradstock; A F Broomhead; W G Hughes; A Kabral; M C Berndt; K Tiver
Monoclonal antibody analysis of canine hemopoietic cells. Role of Ia-like and Thy-1 antigens in bone marrow engraftment.
Transplantation 1986;41(5):565-71.
1986: Kenneth F Bradstock; Emmanuel Favaloro; A Kabral; A Kerr; M Prendergast; M C Berndt; W G Hughes; Heddy Zola; R Krishnan; David N Haylock
Standardization of monoclonal antibodies for use in autologous bone marrow transplantation for common acute lymphoblastic leukemia.
Pathology 1986;18(2):197-205.
1986: J W Hewson; Kenneth F Bradstock; A Kerr; R G Rose
Characterizing "difficult" acute leukemias. A combined electron microscopic and immunological marker study.
Pathology 1986;18(1):99-110.
1985: Kenneth F Bradstock; Emmanuel Favaloro; A Kabral; A Kerr; W G Hughes; E Musgrove
Myeloid progenitor surface antigen identified by monoclonal antibody.
British journal of haematology 1985;61(1):11-20.
1985: Kenneth F Bradstock; Emmanuel Favaloro; A Kabral; A Kerr; W G Hughes; M C Berndt; E Musgrove
Human myeloid differentiation antigens identified by monoclonal antibodies: expression on leukemic cells.
Pathology 1985;17(3):392-9.
1983: Kenneth F Bradstock; J Hewson; A Kerr; A Kabral; C H Lee; W G Hughes
Expression of terminal deoxynucleotidyl transferase in malignant myeloblasts.
American journal of clinical pathology 1983;80(6):800-5.